Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.8500
- TODAY'S CHANGE (%)0.0200 (0.2554%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close7.8300 / 7.8300
- Day Range
- 52 Week Range
- Volume848,271
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 10491 | 7.83 |
| 09:34 ET | 100 | 7.86 |
| 09:36 ET | 718 | 7.9 |
| 09:38 ET | 3386 | 7.7867 |
| 09:39 ET | 1500 | 7.75 |
| 09:41 ET | 1239 | 7.77 |
| 09:43 ET | 2621 | 7.745 |
| 09:45 ET | 3454 | 7.715 |
| 09:48 ET | 17945 | 7.68 |
| 09:50 ET | 11036 | 7.5999 |
| 09:52 ET | 5708 | 7.6 |
| 09:54 ET | 500 | 7.61 |
| 09:56 ET | 5138 | 7.6 |
| 09:57 ET | 3567 | 7.625 |
| 09:59 ET | 2637 | 7.61 |
| 10:06 ET | 3537 | 7.62 |
| 10:08 ET | 2373 | 7.61 |
| 10:10 ET | 4614 | 7.6 |
| 10:12 ET | 16987 | 7.59 |
| 10:14 ET | 7862 | 7.6 |
| 10:15 ET | 500 | 7.62 |
| 10:17 ET | 6537 | 7.66 |
| 10:19 ET | 4441 | 7.67 |
| 10:21 ET | 300 | 7.69 |
| 10:24 ET | 300 | 7.69 |
| 10:26 ET | 800 | 7.665 |
| 10:28 ET | 982 | 7.68 |
| 10:30 ET | 1168 | 7.665 |
| 10:32 ET | 1252 | 7.69 |
| 10:33 ET | 1048 | 7.7 |
| 10:35 ET | 709 | 7.7 |
| 10:37 ET | 1167 | 7.68 |
| 10:39 ET | 602 | 7.69 |
| 10:42 ET | 400 | 7.675 |
| 10:44 ET | 250 | 7.6799 |
| 10:46 ET | 3570 | 7.7 |
| 10:48 ET | 10366 | 7.68 |
| 10:50 ET | 1110 | 7.68 |
| 10:51 ET | 1593 | 7.68 |
| 10:53 ET | 200 | 7.68 |
| 10:55 ET | 100 | 7.68 |
| 10:57 ET | 500 | 7.69 |
| 11:00 ET | 2885 | 7.685 |
| 11:02 ET | 2271 | 7.69 |
| 11:04 ET | 1480 | 7.685 |
| 11:06 ET | 632 | 7.7 |
| 11:08 ET | 2288 | 7.728 |
| 11:09 ET | 564 | 7.75 |
| 11:11 ET | 100 | 7.76 |
| 11:13 ET | 200 | 7.78 |
| 11:15 ET | 860 | 7.8 |
| 11:18 ET | 2513 | 7.78 |
| 11:20 ET | 300 | 7.78 |
| 11:22 ET | 2022 | 7.82 |
| 11:24 ET | 355 | 7.81 |
| 11:26 ET | 4189 | 7.79 |
| 11:27 ET | 200 | 7.79 |
| 11:29 ET | 4179 | 7.82 |
| 11:31 ET | 1800 | 7.845 |
| 11:33 ET | 200 | 7.84 |
| 11:36 ET | 454 | 7.835 |
| 11:38 ET | 3879 | 7.835 |
| 11:40 ET | 21766 | 7.85 |
| 11:44 ET | 200 | 7.87 |
| 11:45 ET | 16062 | 7.87 |
| 11:47 ET | 17937 | 7.78 |
| 11:49 ET | 2030 | 7.77 |
| 11:54 ET | 255 | 7.77 |
| 11:56 ET | 4233 | 7.765 |
| 12:00 ET | 300 | 7.76 |
| 12:02 ET | 113 | 7.755 |
| 12:03 ET | 2209 | 7.735 |
| 12:05 ET | 3670 | 7.73 |
| 12:07 ET | 2815 | 7.75 |
| 12:09 ET | 10262 | 7.75 |
| 12:12 ET | 100 | 7.76 |
| 12:14 ET | 1327 | 7.74 |
| 12:16 ET | 309 | 7.745 |
| 12:18 ET | 1293 | 7.75 |
| 12:20 ET | 300 | 7.76 |
| 12:21 ET | 300 | 7.765 |
| 12:23 ET | 671 | 7.76 |
| 12:25 ET | 808 | 7.775 |
| 12:30 ET | 1572 | 7.765 |
| 12:32 ET | 500 | 7.755 |
| 12:34 ET | 775 | 7.76 |
| 12:36 ET | 3106 | 7.75 |
| 12:38 ET | 2264 | 7.77 |
| 12:39 ET | 300 | 7.78 |
| 12:41 ET | 200 | 7.77 |
| 12:43 ET | 767 | 7.775 |
| 12:45 ET | 800 | 7.79 |
| 12:50 ET | 614 | 7.81 |
| 12:52 ET | 148 | 7.805 |
| 12:54 ET | 2456 | 7.83 |
| 12:56 ET | 1862 | 7.84 |
| 12:57 ET | 1668 | 7.815 |
| 12:59 ET | 3619 | 7.805 |
| 01:01 ET | 791 | 7.79 |
| 01:03 ET | 9658 | 7.815 |
| 01:06 ET | 200 | 7.82 |
| 01:08 ET | 1147 | 7.845 |
| 01:10 ET | 1538 | 7.835 |
| 01:12 ET | 100 | 7.83 |
| 01:14 ET | 1431 | 7.82 |
| 01:15 ET | 200 | 7.82 |
| 01:17 ET | 300 | 7.82 |
| 01:19 ET | 459 | 7.8 |
| 01:21 ET | 2240 | 7.8 |
| 01:26 ET | 1387 | 7.805 |
| 01:28 ET | 4112 | 7.8055 |
| 01:30 ET | 1638 | 7.79 |
| 01:32 ET | 2314 | 7.79 |
| 01:33 ET | 2970 | 7.78 |
| 01:35 ET | 100 | 7.775 |
| 01:37 ET | 1960 | 7.77 |
| 01:39 ET | 1842 | 7.775 |
| 01:42 ET | 1332 | 7.8 |
| 01:44 ET | 1256 | 7.8 |
| 01:46 ET | 1500 | 7.8 |
| 01:48 ET | 1103 | 7.815 |
| 01:50 ET | 620 | 7.815 |
| 01:51 ET | 2021 | 7.84 |
| 01:53 ET | 8425 | 7.835 |
| 01:55 ET | 1834 | 7.84 |
| 01:57 ET | 2366 | 7.85 |
| 02:00 ET | 400 | 7.84 |
| 02:02 ET | 1452 | 7.835 |
| 02:04 ET | 17577 | 7.87 |
| 02:06 ET | 1200 | 7.87 |
| 02:08 ET | 1084 | 7.87 |
| 02:09 ET | 110 | 7.88 |
| 02:11 ET | 4904 | 7.875 |
| 02:13 ET | 3485 | 7.88 |
| 02:15 ET | 5713 | 7.865 |
| 02:18 ET | 9616 | 7.895 |
| 02:20 ET | 1306 | 7.91 |
| 02:22 ET | 800 | 7.9107 |
| 02:24 ET | 5959 | 7.905 |
| 02:26 ET | 1200 | 7.895 |
| 02:27 ET | 1260 | 7.89 |
| 02:29 ET | 3425 | 7.9 |
| 02:31 ET | 3925 | 7.89 |
| 02:33 ET | 3536 | 7.87 |
| 02:36 ET | 900 | 7.8725 |
| 02:38 ET | 200 | 7.87 |
| 02:40 ET | 5024 | 7.8775 |
| 02:42 ET | 1305 | 7.875 |
| 02:44 ET | 6492 | 7.875 |
| 02:45 ET | 968 | 7.875 |
| 02:47 ET | 3914 | 7.9 |
| 02:49 ET | 1351 | 7.895 |
| 02:51 ET | 3400 | 7.87 |
| 02:54 ET | 8585 | 7.84 |
| 02:56 ET | 2157 | 7.831 |
| 02:58 ET | 7933 | 7.855 |
| 03:02 ET | 300 | 7.855 |
| 03:03 ET | 2049 | 7.86 |
| 03:05 ET | 7315 | 7.86 |
| 03:07 ET | 2718 | 7.87 |
| 03:09 ET | 708 | 7.8802 |
| 03:12 ET | 1280 | 7.885 |
| 03:14 ET | 900 | 7.885 |
| 03:16 ET | 1717 | 7.895 |
| 03:18 ET | 2110 | 7.895 |
| 03:20 ET | 4100 | 7.8932 |
| 03:21 ET | 2008 | 7.87 |
| 03:23 ET | 1244 | 7.88 |
| 03:27 ET | 100 | 7.875 |
| 03:30 ET | 674 | 7.87 |
| 03:32 ET | 943 | 7.865 |
| 03:34 ET | 2325 | 7.845 |
| 03:36 ET | 2353 | 7.845 |
| 03:38 ET | 3228 | 7.845 |
| 03:39 ET | 2792 | 7.83 |
| 03:41 ET | 600 | 7.825 |
| 03:43 ET | 5174 | 7.86 |
| 03:45 ET | 3273 | 7.855 |
| 03:48 ET | 1400 | 7.855 |
| 03:50 ET | 3456 | 7.85 |
| 03:52 ET | 15560 | 7.845 |
| 03:54 ET | 3951 | 7.855 |
| 03:56 ET | 20525 | 7.845 |
| 03:57 ET | 11005 | 7.875 |
| 03:59 ET | 104074 | 7.85 |
Sep 10, 2024
*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow JonesVir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 22, 2024
Vir Biotechnology to Participate in the Morgan Stanley 22(nd) Annual Global Healthcare Conference, from 8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.1B | -20.5x | --- |
Zymeworks Inc | 859.7M | -8.0x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.8x | --- |
Silence Therapeutics PLC | 866.0M | -15.5x | --- |
Silence Therapeutics PLC | 866.0M | -14.6x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 13.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
